首页> 外国专利> AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune diseases and IL-17A-related diseases

AhR-ROR-γt complex as a biomarker and therapeutic target for autoimmune diseases and IL-17A-related diseases

机译:AHR-ROR-γT复合物作为自身免疫疾病和IL-17A相关疾病的生物标志物和治疗靶标

摘要

A method of identifying an AhR-phospho-RORγt protein complex inhibitor, comprising: (a) providing a cell culture in which cells in the culture express AhR protein and phospho-RORγt protein; (b) incubating the cell culture in the presence of a test agent; (c) analyzing the level of the AhR-phospho-RORγt protein complex in the presence of the test agent; (d) comparing the level of the AhR-phospho-RORγt protein complex in the presence of the test agent with a control; And (e) when the comparison step indicates that there is a decrease in the level of the AhR-phospho-RORγt protein complex in the presence of the test agent compared to the control, the test agent is used as the AhR-phospho-RORγt protein complex. And identifying as an inhibitor of. Methods of identifying GLK-IQGAP1 protein complex inhibitors are also disclosed. The use of the identified inhibitors in the manufacture of a medicament for treating a disease is also disclosed.
机译:一种鉴定AHR-磷酸-RORγT蛋白复合抑制剂的方法,包括:(a)提供细胞培养物,其中培养物表达AHR蛋白和磷酸-RORγT蛋白中的细胞; (b)在测试剂存在下孵育细胞培养物; (c)在试剂存在下分析AHR-磷酸-RORγT蛋白复合物的水平; (d)将AHR-磷酸-RORγT蛋白质复合物的水平与对照的试剂存在; (e)当比较步骤表明在测试剂的情况下,与对照相比,测试剂在测试剂存在下的AHR-磷酸-RORγT蛋白复合物的水平降低,测试剂用作AHR-Phoplo-RORγT蛋白质复合物。并鉴定为抑制剂。还公开了鉴定GLK-IQGAP1蛋白复合物抑制剂的方法。还公开了在制备治疗疾病的药物中的鉴定抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号